Related Experiment Videos
L-Ornithine decarboxylase:an essential role in early mammalian embryogenesis
Abstract:
The highly selective, enzyme-activated, irreversible inhibitor of L-ornithine decarboxylase, DL-alpha-difluoromethylornithine, suppresses the increase in uterine L-ornithine decarboxylase activity associated with early embryogenesis in the mouse and arrests embryonic development at that stage. Contragestational effects were confirmed in the rat and rabbit. An increase in L-ornithine decarboxylase activity that leads to a rapid increase in putrescine concentration appears to be essential during a critical period after implantation for continued mammalian embryonal growth.
Insights
DL-alpha-difluoromethylornithine, an inhibitor of L-ornithine decarboxylase, stops early mammalian embryo development. This enzyme activity is crucial for embryonal growth after implantation.
Area of Science:
- Reproductive biology
- Developmental biology
- Biochemistry
Background:
- Early embryogenesis requires precise regulation of enzyme activity.
- L-ornithine decarboxylase (ODC) activity increases significantly during early mammalian development.
- Putrescine, a polyamine, is a key product of ODC and essential for cell growth.
Purpose of the Study:
- To investigate the role of L-ornithine decarboxylase in early mammalian embryogenesis.
- To determine the effects of DL-alpha-difluoromethylornithine (DFMO) on embryonic development.
- To confirm the contragestational potential of ODC inhibition.
Main Methods:
- Administration of DFMO, a selective ODC inhibitor, to pregnant mice, rats, and rabbits during critical developmental periods.
- Measurement of uterine ODC activity and putrescine concentrations.
- Assessment of embryonic development and viability.
Main Results:
- DFMO effectively suppressed the rise in uterine ODC activity during early embryogenesis in mice.
- Embryonic development was arrested at the stage of increased ODC activity in DFMO-treated mice.
- Contragestational effects of DFMO were confirmed in rats and rabbits, indicating species-wide relevance.
- The study highlights the essential role of increased ODC activity and subsequent putrescine production for post-implantation embryonic growth.
Conclusions:
- Inhibition of L-ornithine decarboxylase by DFMO disrupts early mammalian embryonic development.
- ODC activity and putrescine synthesis are critical for the continuation of embryonal growth following implantation.
- DFMO demonstrates contragestational effects, suggesting a potential therapeutic target for pregnancy interruption.